In 2023, China's share of scientific publications in nephrology among the world's top 10% most-cited stood at 8.68%. Forecast data suggests a steady increase, reaching 9.22% by 2028. Year-on-year growth is relatively stable, with an average annual increase of approximately 0.11 percentage points. Over the 5-year period, this reflects a compound annual growth rate (CAGR) of roughly 1.21%.

Future trends to watch for:

Advancements in nephrology research outputs in China might enhance its global share of top-cited papers.
Policies promoting scientific collaboration could further accelerate growth in publication impact.
Monitoring international collaborations and funding allocation could provide insights into sustaining this upward trend.